Your browser doesn't support javascript.
loading
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin.
Wollenhaupt, Jan; Barthel, Tatjana; Lima, Gustavo M A; Metz, Alexander; Wallacher, Dirk; Jagudin, Elmir; Huschmann, Franziska U; Hauß, Thomas; Feiler, Christian G; Gerlach, Martin; Hellmig, Michael; Förster, Ronald; Steffien, Michael; Heine, Andreas; Klebe, Gerhard; Mueller, Uwe; Weiss, Manfred S.
Affiliation
  • Wollenhaupt J; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Barthel T; Macromolecular Crystallography, Helmholtz-Zentrum Berlin; Structural Biochemistry Group, Institute for Chemistry and Biochemistry, Freie Universität Berlin.
  • Lima GMA; BioMAX, MAX IV Laboratory.
  • Metz A; Drug Design Group, Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg.
  • Wallacher D; Department Sample Environment, Helmholtz-Zentrum Berlin.
  • Jagudin E; BioMAX, MAX IV Laboratory.
  • Huschmann FU; Macromolecular Crystallography, Helmholtz-Zentrum Berlin; Drug Design Group, Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg.
  • Hauß T; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Feiler CG; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Gerlach M; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Hellmig M; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Förster R; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Steffien M; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Heine A; Drug Design Group, Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg.
  • Klebe G; Drug Design Group, Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg.
  • Mueller U; Macromolecular Crystallography, Helmholtz-Zentrum Berlin.
  • Weiss MS; Macromolecular Crystallography, Helmholtz-Zentrum Berlin; msweiss@helmholtz-berlin.de.
J Vis Exp ; (169)2021 03 03.
Article in En | MEDLINE | ID: mdl-33749678
Fragment screening is a technique that helps to identify promising starting points for ligand design. Given that crystals of the target protein are available and display reproducibly high-resolution X-ray diffraction properties, crystallography is among the most preferred methods for fragment screening because of its sensitivity. Additionally, it is the only method providing detailed 3D information of the binding mode of the fragment, which is vital for subsequent rational compound evolution. The routine use of the method depends on the availability of suitable fragment libraries, dedicated means to handle large numbers of samples, state-of-the-art synchrotron beamlines for fast diffraction measurements and largely automated solutions for the analysis of the results. Here, the complete practical workflow and the included tools on how to conduct crystallographic fragment screening (CFS) at the Helmholtz-Zentrum Berlin (HZB) are presented. Preceding this workflow, crystal soaking conditions as well as data collection strategies are optimized for reproducible crystallographic experiments. Then, typically in a one to two-day procedure, a 96-membered CFS-focused library provided as dried ready-to-use plates is employed to soak 192 crystals, which are then flash-cooled individually. The final diffraction experiments can be performed within one day at the robot-mounting supported beamlines BL14.1 and BL14.2 at the BESSY  II electron storage ring operated by the HZB in Berlin-Adlershof (Germany). Processing of the crystallographic data, refinement of the protein structures, and hit identification is fast and largely automated using specialized software pipelines on dedicated servers, requiring little user input. Using the CFS workflow at the HZB enables routine screening experiments. It increases the chances for successful identification of fragment hits as starting points to develop more potent binders, useful for pharmacological or biochemical applications.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crystallography, X-Ray / Drug Evaluation, Preclinical Type of study: Diagnostic_studies / Screening_studies Country/Region as subject: Europa Language: En Journal: J Vis Exp Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crystallography, X-Ray / Drug Evaluation, Preclinical Type of study: Diagnostic_studies / Screening_studies Country/Region as subject: Europa Language: En Journal: J Vis Exp Year: 2021 Document type: Article Country of publication: United States